Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT04574635

Human Papilloma Virus (HPV) Circulating Tumor DNA (ctDNA) in Cervical Cancer

Status
Active Not Recruiting
Phase
—
Study type
Observational
Enrollment
18 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study collects blood samples to determine if the DNA of HPV that causes cervical cancer can be detected in patients with cervical cancer that is new (primary), has come back (recurrent), or has spread to other places in the body (metastatic) and are undergoing treatment with surgery, radiotherapy, chemotherapy, and/or immunotherapy. Researchers may use this information to predict response (good or bad) of the cervical cancer to treatment and detect recurrent cancer sooner.

Conditions

Interventions

TypeNameDescription
PROCEDUREBiospecimen CollectionUndergo collection of blood samples

Timeline

Start date
2020-11-17
Primary completion
2025-09-10
Completion
2027-11-30
First posted
2020-10-05
Last updated
2025-10-27

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT04574635. Inclusion in this directory is not an endorsement.